𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer

✍ Scribed by Kunyu Yang; Tao Zhang; Jing Chen; Li Fan; Zhongyuan Yin; Yu Hu; Gang Wu

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
261 KB
Volume
34
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome.

Methods

We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patient underwent definitive intensity‐modulated radiation therapy (IMRT) in combination with concurrent cetuximab, the other with cisplatin. Both patients received adjuvant chemotherapy composed of docetaxel and cisplatin.

Results

The cause of their grade III thrombocytopenia was diagnosed as immunologic in origin. Prednisone was administered before IMRT, and their peripheral platelet counts recovered to normal levels. Their platelet counts fell below normal levels several times during their treatment. However, their radiotherapy and chemotherapy had never been interrupted due to thrombocytopenia.

Conclusion

Grade III thrombocytopenia is a rare paraneoplastic syndrome in patients with NPC. These patients can tolerate the aggressive definitive management of radiotherapy and chemotherapy with supportive care. Β© 2010 Wiley Periodicals, Inc. Head Neck, 2012

πŸ“œ SIMILAR VOLUMES

Percutaneous coronary intervention in a
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura
✍ George A. Stouffer; Jana Hirmerova; Stephan Moll; Bryon Rubery; Mark Napoli; E. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 142 KB πŸ‘ 2 views

## Abstract The appropriate regimen of platelet inhibitors that should be used in patients with immune thrombocytopenia purpura (ITP; formerly called idiopathic thrombocytopenic purpura) who are undergoing percutaneous coronary intervention is unclear. We report the case of a patient with ITP who u

Paraneoplastic Cushing's syndrome as an
Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer
✍ Meletios A. Dimopoulos; Jose F. Fernandez; Naguib A. Samaan; Paul Y. Holoye; Ren πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 551 KB

The potential role of paraneoplastic Cushing's syndrome (CS) was assessed on the clinical course of patients with small cell lung cancer. A retrospective comparison was done of complications and survival rates according to the presence or absence of CS in patients with small cell lung cancer who die

Immunity to antigens associated with a c
Immunity to antigens associated with a cell line derived from nasopharyngeal cancer (NPC) in non-Chinese NPC patients
✍ P. H. Levine; R. B. Herberman; J. C. Ambrosioni; G. B. De-ThΓ©; J. Brugere; G. Sc πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 French βš– 525 KB

## Abstract Delayed hypersensibility to antigens derived from four lymphoid cell lines was measured in 27 non‐Chinese patients with nasopharyngeal cancer (NPC) and 63 non‐NPC cancer patients. Of the NPC patients, 17/27 (63%) had a positive skin test response to antigens derived from HKLY‐28, a lymp